A 56-year-old man with long-standing type 2 diabetes (HbA1c 8.4%) and obesity (BMI 34 kg/m²) is on maximum tolerated metformin. He has established ath...

Question

A 56-year-old man with long-standing type 2 diabetes (HbA1c 8.4%) and obesity (BMI 34 kg/m²) is on maximum tolerated metformin. He has established atherosclerotic cardiovascular disease but preserved renal function. According to current Australian algorithms, what is the MOST appropriate next glucose-lowering agent?

Accepted Answer

Add an SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit

Answer

Add a sulfonylurea

Answer

Add a DPP-4 inhibitor

Answer

Switch metformin to insulin

Answer

No additional therapy is required as HbA1c is acceptable

au-racp MCQ (SBA): Type 2 diabetes mellitus with cardiovascular disease